Target intelligence / Profile preview

Cellular entry receptors and tumor-associated determinants

Molecular classification
Other
01

Overview

Cellular entry receptors and tumor-associated determinants is a descriptive term used in pharmacological databases to categorize the complex mechanism of action for oncolytic viruses, most notably Pelareorep (Reolysin). Pelareorep is an isolate of the mammalian orthoreovirus type 3 Dearing that selectively infects and lyses malignant cells. The virus utilizes Junctional Adhesion Molecule A (JAM-A) as its primary high-affinity entry receptor and sialic acid as a low-affinity co-receptor (Barton et al., 2001, Cell; Reiter et al., 2011, J Virol). The 'tumor-associated determinants' refer to the intracellular environment, specifically an activated Ras signaling pathway; in normal cells, Protein Kinase R (PKR) prevents viral replication, but in Ras-activated cancer cells, PKR is inhibited, allowing the virus to replicate and cause oncolysis (Strong et al., 1998, EMBO J). This selective process leads to direct tumor cell death and the subsequent release of viral progeny and tumor antigens, which can trigger a systemic anti-tumor immune response.

Other names
Unknown cellular entry receptors and tumor-associated determinantsPelareorep targetsReovirus entry receptorsJAM-A and Ras pathway
02

Mechanism of action

Selective oncolytic viral replication and induction of anti-tumor immunity

03

Biological functions

Viral entryImmune responseCell deathOther
04

Disease associations

Cancer
05

Safety considerations

Neutralizing antibody formationFlu-like symptomsViral shedding
06

Interacting drugs

Pelareorep
07

Biomarkers

Ras mutation statusJunctional adhesion molecule A (JAM-A) expression

Beyond the preview

Go deeper on Cellular entry receptors and tumor-associated determinants.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular entry receptors and tumor-associated determinants.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call